Series B - Alebund Pharmaceuticals - Sep 13, 2021 Funding Round Profile - Cointime

Bitcoin $79,577.27 +4.05%
Ethereum $3,208.19 +5.45%
BNB $635.62 +1.49%
Optimism $1.66 +1.10%
Arbitrum $0.64 +4.98%
Solana $205.26 +1.18%
Polygon $0.41 +5.40%
Cosmos $5.23 +9.68%
Avalanche $31.87 +7.76%

Bitcoin $79,577.27 +4.05%
Ethereum $3,208.19 +5.45%
BNB $635.62 +1.49%
Optimism $1.66 +1.10%
Arbitrum $0.64 +4.98%
Solana $205.26 +1.18%
Polygon $0.41 +5.40%
Cosmos $5.23 +9.68%
Avalanche $31.87 +7.76%

Alebund Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 54.50M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
May 9, 2021	Series B	$ 60M	Lilly Asia Ventures	Detail
Jan 1, 2020	Series A	0	Lilly Asia Ventures	Detail